NIH eases investment rules for employees

08/26/2005 | Bloomberg Businessweek

The National Institutes of Health eased some of its proposed ethics rules, saying just 200 senior staffers and their families would be limited to owning no more than $15,000 worth of stock in pharmaceutical and biotechnology companies. An earlier proposal would have banned any such holdings for about 6,000 employees and limited the amount for 12,000 others, which angered many of the agency's workers and threatened to make it difficult to attract new staffers. The final ethics rules retain a ban on consulting work for drug companies.

View Full Article in:

Bloomberg Businessweek

Published in Brief:

SmartBrief Job Listings for Health Care